Fate Therapeutics (FATE) Return on Sales (2012 - 2026)
Fate Therapeutics (FATE) reported Return on Sales of 0.24% for Q1 2026, down 1.0% on a YoY basis from 0.24% in Q1 2025, and down 0.95% quarter-over-quarter from 0.24% in Q4 2025.
Fate Therapeutics (FATE) Return on Sales (2012 - 2026) Analysis & Trends
Fate Therapeutics has reported Return on Sales for 14 years, with the latest figure at 0.24% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales fell 1.0% year-over-year to 0.24%; the trailing twelve-month figure through Mar 2026 stood at 0.21% (down 7.0% YoY), and the FY2025 full-year result was 0.21%, down 6.0% from the prior year.
- Return on Sales for Q1 2026 stood at 0.24%, down from 0.24% in the prior quarter.
- The five-year high for Return on Sales was 0.0% in Q1 2023, with the low at 0.62% in Q2 2023.
- Historically, Return on Sales has averaged 0.18% across 5 years, with a median of 0.18% in 2025.
- Annual changes were most pronounced in 2023 — Return on Sales plunged 58 bps — and 2024, when it jumped 56 bps.
- Fate Therapeutics' Return on Sales stood at 0.01% in 2022, then slumped by 1778 bps to 0.26% in 2023, then fell by 19 bps to 0.31% in 2024, then rose by 24 bps to 0.24% in 2025, then decreased by 1 bps to 0.24% in 2026.
- The last three Return on Sales figures came in at 0.24% (Q1 2026), 0.24% (Q4 2025), and 0.18% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fate Therapeutics | 250.86 Mn | 250.86 Mn | - | -0.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.24% |
| Dec 31, 2025 | -0.24% |
| Sep 30, 2025 | -0.18% |
| Jun 30, 2025 | -0.18% |
| Mar 31, 2025 | -0.23% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | -0.16% |
| Jun 30, 2024 | -0.06% |
| Mar 31, 2024 | -0.24% |
| Dec 31, 2023 | -0.26% |
| Sep 30, 2023 | -0.24% |
| Jun 30, 2023 | -0.62% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.04% |
| Mar 31, 2022 | -0.04% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | -0.04% |
| Jun 30, 2021 | -0.03% |